Omega-3 fatty acids: Structure, function, and relation to the metabolic syndrome, infertility and pregnancy

Metabolic Syndrome and Related Disorders

Volumn 4, Issue 2, 2006, Pages 138-148

  Saldeen, Pia ^a,b   Saldeen, Tom ^c  

^a LUND UNIVERSITY   (Sweden)

^b IVF Clinic CURA   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBOHYDRATE; DOCOSAPENTAENOIC ACID; DOCOSATRIENE DERIVATIVE; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INSULIN; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; METHYLPREDNISOLONE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PLACEBO; POLYUNSATURATED FATTY ACID; PRIMROSE OIL; PROPRANOLOL; PROTECTIN DERIVATIVE; RESOLVIN DERIVATIVE; SATURATED FATTY ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CALORIC RESTRICTION; CARBOHYDRATE DIET; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG RECEPTOR BINDING; EDEMA; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FISH; FOOD INTAKE; HIGH RISK PREGNANCY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY RATE; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 33746445468     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2006.4.138     Document Type: Review

References (56)

1. Saldeen T. All about omega-3. The vitamin from the ocean. SwedeHealth Press 2006:1-158.
2. Wahl HG, Liebich HM, Hoffman A. Identification of fatty acid methyl esters as minor components of fish oil by multidimensional GC-MSD: new furan fatty acids. J High Resol Chromatogr 1994;17:308-311.
3. Spitteler G. Furan fatty acids: occurrence, synthesis, and reactions. Are furan fatty acids responsible for the cardioprotective effects of a fish diet? Lipids 2005;40:755-771.
4. Spitteler G. The realtion of lipid peroxidation processes with atherogenesis: a new theory of atherogenesis. Mol Nutr Food Res 2005;49:999-1013.
5. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac R-L. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J Exp Med 2002;196:1025-1037.
6. Serhan CN, Arita M, Hong S, Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3 derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004;39:1125-1132.
7. Clarke SD, Thuillier P, Baillie RA, Sha X. Peroxisome proliferators activated receptors: a family of lipid-activated transcription factors. Am J Clin Nutr 1999; 70:566-571.
8. Jump DB, Clarke SD, Thelen A, Liimatta M, Ren B, Badin M. Dietary polyunsaturated fatty acid regulation of gene transcription. Prog Lipid Res 1996;35: 227-241.
9. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferators-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 1996;37:907-925.
10. Singer P, Melzer S, Goschel M, Augustin S. Fish oil amplifies the effect of propranolol in mild essential hypertension. Hypertension 1990;16:682-691.
11. Haglund O, Landelius J, Luostarinen R, Alving B, Saldeen T. Fish oil improves arterial compliance [in Swedish]. Hygiea 1990;99:303.
12. Haglund O, Wallin R, Luostarinen R, Saldeen T. Effects of a new fluid fish oil concentrate, Eskimo-3, on triglycerides, cholesterol, fibrinogen and blood pressure. J Intern Med 1990;227:347-353.
13. McVeigh GE, Brennan GM, Cohn JN, Finkelstein SM, Hayes RJ, Johnston GD. Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler Thromb 1994;14:1425-1429.
14. Nestel P, Shige H, Pomeroy S, Cehun M, Abbey M, Raederstorff D. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr 2002;76: 325-330.
15. Knapp HR. Hypotensive effects of w-3 fatty acids: mechanistic aspects. In: Health effects of w-3 polyunsaturated fatty acids in seafood. World Rev Nutr Diet 1991;313-328.
16. Damsgaard CT, Schack-Nielsen L, Michaelsen KF, Fruekilde M-B, Hels O, Lauritzen L. Fish oil affects blood pressure and the plasma lipid profile in healthy Danish infants. J Nutr 2006;136:94-99.
17. Luostarinen R, Wallin R, Wibell L, Saldeen T. Vitamin E supplementation counteracts the fish oil-induced increase of blood glucose in humans. Nutr Res 1995;15:953-968.
18. Tsitouris PD, Gucciardo F, Salbe AD, Harman SM. High omega-3 oral intake improves insulin sensitivity but does not affect other endocrine axes in older healthy adults. Presented at the Endocrine Society Meeting, 2005.
19. Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nälsen C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gustafsson I-B, Storlien LH. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study. Diabetologia 2001;44: 312-319.
20. Borkman M, Chisholm DJ, Furler SM, Storlien LH, Kraegen EW, Simons LA, Chesterman CN. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes 1989;38:1314-1319.
21. Annuzzi G, Rivellese A, Capaldo B, Di Marino L, Iovine C, Marotta G, Riccardi G. A controlled study on the effects of n = 3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients. Atherosclerosis 1991;87:65-73.
22. Boberg M, Pollare T, Siegbahn A, Vessby B. Supplementation with n-3 fatty acids reduces triglycerides but increases PAI-1 in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1992;22:645-650.
23. McManus RM, Jumpson J, Finegood DT, Clandinin MT, Ryan EA. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care 1996;19:463-476.
24. Rivellese AA, Maffettone A, Iovine C, Di Marino L, Annuzzi G, Mancini M, Riccardi G. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care 1996;19:1207-1213.
25. Luo J, Rizkalla SW, Vidal H, Oppert JM, Colas C, Boussairi A, Guerre-Millo M, Chapuis AS, Chevalier A, Durand G, Slama G. Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study. Diabetes Care 1998;21:717-724.
26. Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of Type 1 diabetes in the offspring. Diabetologia 2000; 43:1093-1098.
27. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-219.
28. Suzukawa M, Abbey M, Howe PR. Effects of fish oil fatty acids on low-density lipoprotein size, oxidizability, and uptake by macrophages. J Lipid Res 1995; 36:473-484.
29. Minihane AM, Khan S, Leigh-Firbank EC, Talmud P, Wright JW, Murphy MC, Griffin BC, Williams CM. ApoE polymorfism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol 2000;20:1990-1997.
30. Rubinstein M, Maeazzi A, Polak de Fried E. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blod flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay. Fertil Steril 1999;71:825-829.
31. Engström K, Luostarinen R, Saldeen T. Whole blood production of thromboxane, prostacyclin and leukotriene B4 after dietary fish oil supplementation in man: effect of vitamin E. Prostaglandins Leukot Essent Fatty Acids 1996;54:419-425.
32. Polak de Fried E, Blanco L, Lancuba S, et al. Improvement of clinical pregnancy rate and implantation rate of in vitro fertilization-embryo transfer patients by using methylprednisolone. Hum Reprod 1993;8:393-395.
33. Velazquez EM, Mendoza SG, Wang P, et al. Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-11, lipoprotein (a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. Metabolism 1997;46:454-457.
34. Kiddy DS, Hamilton-Fairly D, Bush A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 1992;36: 105-111.
35. Olsen SF, Sörensen JD, Secher NJ, et al. Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 1992;339:1003-1007.
36. Olsen SF, Secher NJ. Low consumption of seafood early in pregnancy as a risk factor for preterm delivery: prospective cohort study. BMJ 2002;324:1-5.
37. Olsen SF, Secher NJ, Tabor A, et al. Randomized clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials in Pregnancy (FOTIP) Team. Br J. Obstet Gynaecol 2000;107:382-395.
38. Olsen SF, Hansen FS, Sörensen TIA, et al. Intake of marine fat, rich in (n-3)-PUFA, may increase birthweight by prolonging gestation. Lancet 1986;2:367-369.
39. Al MD, van Houwelingen AC, Hornstra G. Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome. Am J Clin Nutr 2000;71:285S-291S.
40. People's League of Health. The nutrition of expectanat and nursing mothers in relation to maternal and infant mortality and morbidity. J Obstet Gynaecol Br Emp 1946;53:498-509.
41. Smuts CM, Huang M, Mundy D, et al. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 203;101:469-479.
42. Onwude JL, Lilford RJ, Hjartardottir H, et al. A randomised double-blind placebo-controlled trial of fish oil in high-risk pregnancy. Br J Obstet Gynaecol 1995;102:95-100.
43. Bulstra-Ramakers MT, Huisjes HJ, Vissher GH. The effects of 3 g daily eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy-induced hypertension. Br J Obstet Gynaecol 1995;102:123-126.
44. Helland IB, Saugstad OD, Smith L, et al. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 2001;108:E82.
45. Olsen SF. Is supplementation with marine omega-3 fatty acids during pregnancy a useful tool in the prevention of preterm birth? Clin Obstet Gynecol 2004; 47:768-774.
46. Popp-Snijders C, Schouten JA, Heine RJ, et al. Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Res 1987;4:141-147.
47. Saldeen P, Olofsson P, Marsal K. Lack of association between Doppler velocimetry and synthesis of prostacyclin and thromboxane in umbilical cord vessels from growth retarded fetuses. Acta Obstet Gynecol Scand 1995;74:103-108.
48. Saldeen P. Studies on prostanoid production in the umbilicoplacental circulation [Doctoral thesis]. Lund, Sweden: University of Lund, 2002.
49. Saldeen P, Olofsson P, Parhar RS, et al. Prostanoid production in umbilical vessels and its relation to glucose tolerance and umbilical artery flow resistance. Eur J Obstet Gynecol Reprod Biol 1996;68:35-41.
50. Saldeen P, Olofsson P, Parhar RS, et al. Prostanoid production in the umbilico-placental arterial tree relative to impaired glucose tolerance. Early Hum Dev 1998;50:175-183.
51. Saldeen P, Olofsson P, Laurini RN. Structural, functional and circulatory placental changes associated with impaired glucose metabolism. Eur J Obstet Gynecol Reprod Biol 2002;105:136-142.
52. Saldeen P, Olofsson P, Laurini RN. Signs of platelet activation, but not lipid peroxidation, in fetal blood associated with functional and structural umbilicoplacental lesions in pregnancies complicated by impaired glucose metabolism. J Matern Fetal Neonatal Med 2002;12:165-171.
53. Velsing-Arts FV, van der Klis FRM, van der Dijs FPL, et al. Effect of three low-dose fish oil supplements, administered during pregnancy, on neonatal long-chain polyunsaturated fatty acid status at birth. Prostaglandins Leukot Essent Fatty Acids 2001;65: 51-57.
54. Barker DJP, Gluckman PD, Godfrey KM, et al. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993;341:938-941.
55. Mills JL, DerSimonian R, Raymond E, et al. Prostacyclin and thromboxane changes predating clinical onset of preeclampsia. A multicenter prospective study. JAMA 1999;282:356-362.
56. D'Almeida A, Carter JP, Anatol A, et al. Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docosahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women's Health 1992;19:1178-1131.